Interstitial lung disease (ILD) is common in systemic sclerosis (SSc) patients and despite
recent advances in the treatment is, at present, the major cause of death. Today, an early …

Diffuse lung disorders (DLDs) and interstitial lung diseases (ILDs) are pathological
conditions affecting the lung parenchyma and interstitial network. There are approximately …

The characteristics and evolution of pulmonary fibrosis in patients with coronavirus disease
2019 (COVID-19) have not been adequately studied. AI-assisted chest high-resolution …

Lung densitometry assesses with computed tomography (CT) the X-ray attenuation of the
pulmonary tissue which reflects both the degree of inflation and the structural lung …

Deep learning methods have gained increasing attention in addressing segmentation
problems for medical images analysis despite the challenges inherited from the medical …

Objectives To evaluate an improved quantitative lung fibrosis score based on a computer-
aided diagnosis (CAD) system that classifies CT pixels with the visual semi-quantitative …

Interstitial lung disease (ILD) is the leading cause of morbidity and mortality in systemic
sclerosis (SSc). We performed a systematic review to characterise the use and validation of …

Rationale and Objectives Median survival of patients with idiopathic pulmonary fibrosis (IPF)
is 2–5 years. Sensitive imaging metrics can play a role in detecting early changes in …

The diagnosis and classification of systemic sclerosis-associated interstitial lung disease
(SSc-ILD) is essential to improve the prognosis of systemic sclerosis (SSc) patients. The risk …

Background Longitudinal follow-up of interstitial lung diseases (ILDs) at CT mainly relies on
the evaluation of the extent of ILD, without accounting for lung shrinkage. Purpose To …